ClearBridge Investments
TECH icon

ClearBridge Investments’s Bio-Techne TECH Stock Holding History

ClearBridge Investments’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.3M Sell
428,316
-604,632
-59% -$32.6M 0.03% 391
2026
Q1 		$54M Buy
1,032,948
+84,436
+9% +$5.07M 0.05% 296
2025
Q4 		$55.8M Sell
948,512
-6,319
-0.7% -$384K 0.04% 307
2025
Q3 		$53.1M Buy
954,831
+541,024
+131% +$29M 0.04% 319
2025
Q2 		$21.3M Sell
413,807
-385,193
-48% -$19.4M 0.02% 409
2025
Q1 		$46.8M Sell
799,000
-2,625
-0.3% -$178K 0.04% 314
2024
Q4 		$57.7M Sell
801,625
-159,594
-17% -$11.7M 0.05% 295
2024
Q3 		$76.8M Sell
961,219
-32,739
-3% -$2.46M 0.06% 269
2024
Q2 		$71.2M Sell
993,958
-63,686
-6% -$4.69M 0.06% 272
2024
Q1 		$74.4M Sell
1,057,644
-10,506
-1% -$752K 0.06% 282
2023
Q4 		$82.4M Sell
1,068,150
-6,832
-0.6% -$450K 0.07% 268
2023
Q3 		$73.2M Buy
1,074,982
+6,520
+0.6% +$515K 0.07% 253
2023
Q2 		$87.2M Buy
1,068,462
+192,880
+22% +$15.5M 0.08% 247
2023
Q1 		$65M Sell
875,582
-89,702
-9% -$6.91M 0.06% 269
2022
Q4 		$80M Buy
965,284
+112,052
+13% +$8.9M 0.08% 241
2022
Q3 		$60.6M Buy
853,232
+2,592
+0.3% +$224K 0.06% 279
2022
Q2 		$73.7M Buy
850,640
+22,804
+3% +$2.14M 0.07% 256
2022
Q1 		$89.6M Sell
827,836
-4,348
-0.5% -$449K 0.07% 262
2021
Q4 		$108M Sell
832,184
-2,104
-0.3% -$258K 0.07% 237
2021
Q3 		$101M Sell
834,288
-5,764
-0.7% -$701K 0.07% 232
2021
Q2 		$94.6M Sell
840,052
-3,244
-0.4% -$341K 0.07% 247
2021
Q1 		$80.5M Buy
843,296
+1,448
+0.2% +$132K 0.06% 261
2020
Q4 		$66.8M Sell
841,848
-16,800
-2% -$1.22M 0.05% 285
2020
Q3 		$53.2M Buy
858,648
+4,416
+0.5% +$287K 0.05% 280
2020
Q2 		$56.4M Buy
854,232
+363,160
+74% +$21.7M 0.05% 256
2020
Q1 		$23.3M Buy
+491,072
New +$24.6M 0.03% 347
2014
Q3 		– Sell
-4,176
Closed -$97K – 1203
2014
Q2 		$97K Buy
+4,176
New +$92.3K ﹤0.01% 895

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HBK Investments
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

ClearBridge Investments's TECH Position: Q2 2026 in Review

ClearBridge Investments reduced its Bio-Techne (TECH) stake by 59% in Q2 2026, selling an estimated $32.6M and leaving 428,316 shares worth $30.3M. The position accounts for 0.03% of the portfolio, ranked #391.

ClearBridge Investments first reported a position in TECH in Q2 2014 and has held it in 27 quarters since. The position peaked at $108M in Q4 2021. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • ClearBridge Investments held 428,316 shares of Bio-Techne worth $30.3M as of Q2 2026.
  • ClearBridge Investments sold 604,632 Bio-Techne shares in Q2 2026, an estimated $32.6M.
  • Bio-Techne made up 0.03% of ClearBridge Investments's portfolio in Q2 2026, its #391 holding.
  • ClearBridge Investments first reported a position in Bio-Techne in Q2 2014 and has held it in 27 quarters since.
  • ClearBridge Investments's Bio-Techne position peaked at $108M in Q4 2021.
  • 597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.